FR2189034A2 - - Google Patents
Info
- Publication number
- FR2189034A2 FR2189034A2 FR7321743A FR7321743A FR2189034A2 FR 2189034 A2 FR2189034 A2 FR 2189034A2 FR 7321743 A FR7321743 A FR 7321743A FR 7321743 A FR7321743 A FR 7321743A FR 2189034 A2 FR2189034 A2 FR 2189034A2
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2811872A GB1434919A (en) | 1972-06-15 | 1972-06-15 | 3alpha-hydroxy androstanes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2189034A2 true FR2189034A2 (enExample) | 1974-01-25 |
| FR2189034B2 FR2189034B2 (enExample) | 1977-01-21 |
Family
ID=10270562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7321743A Expired FR2189034B2 (enExample) | 1972-06-15 | 1973-06-14 |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE800899R (enExample) |
| CA (1) | CA1040619A (enExample) |
| DE (1) | DE2330342A1 (enExample) |
| DK (1) | DK136157B (enExample) |
| FR (1) | FR2189034B2 (enExample) |
| GB (1) | GB1434919A (enExample) |
| LU (1) | LU67790A1 (enExample) |
| NL (1) | NL7308267A (enExample) |
| ZA (1) | ZA734037B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160068563A1 (en) | 2013-04-17 | 2016-03-10 | Boyd L. Harrison | 19-nor neuroactive steroids and methods of use thereof |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| EP2986623B1 (en) | 2013-04-17 | 2018-11-07 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof |
| HUE051403T2 (hu) | 2013-04-17 | 2021-03-01 | Sage Therapeutics Inc | Neuroaktív 19-nor-szteroidok kezelési eljárásokhoz |
| LT3021852T (lt) | 2013-07-19 | 2021-04-12 | Sage Therapeutics, Inc. | Neuroaktyvūs steroidai, jų kompozicijos ir panaudojimas |
| EP3035940B1 (en) | 2013-08-23 | 2018-10-17 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| CN112961206A (zh) | 2014-10-16 | 2021-06-15 | 萨奇治疗股份有限公司 | 靶向cns障碍的组合物和方法 |
| EP3206493B1 (en) | 2014-10-16 | 2020-05-06 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| HUE049014T2 (hu) | 2014-11-27 | 2020-09-28 | Sage Therapeutics Inc | Készítmények és módszerek a központi idegrendszer rendellenességeinek kezelésére |
| ES2857082T3 (es) | 2015-01-26 | 2021-09-28 | Sage Therapeutics Inc | Composiciones y métodos para el tratamiento de trastornos del SNC |
| US10329320B2 (en) | 2015-02-20 | 2019-06-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| NZ790187A (en) | 2016-07-11 | 2025-08-29 | Sage Therapeutics Inc | C7, C12, and C16 substituted neuroactive steroids and their methods of use |
| NZ790225A (en) | 2016-07-11 | 2025-08-29 | Sage Therapeutics Inc | C17, C20, and C21 substituted neuroactive steroids and their methods of use |
| CN114206900A (zh) | 2019-05-31 | 2022-03-18 | 萨奇治疗股份有限公司 | 神经活性类固醇及其组合物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| FR2118117A1 (enExample) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd | |
| FR2118123A1 (enExample) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd |
-
1972
- 1972-06-15 GB GB2811872A patent/GB1434919A/en not_active Expired
-
1973
- 1973-06-14 CA CA174,050A patent/CA1040619A/en not_active Expired
- 1973-06-14 FR FR7321743A patent/FR2189034B2/fr not_active Expired
- 1973-06-14 ZA ZA734037A patent/ZA734037B/xx unknown
- 1973-06-14 DK DK328673AA patent/DK136157B/da unknown
- 1973-06-14 DE DE2330342A patent/DE2330342A1/de not_active Ceased
- 1973-06-14 LU LU67790A patent/LU67790A1/xx unknown
- 1973-06-14 NL NL7308267A patent/NL7308267A/xx not_active Application Discontinuation
- 1973-06-14 BE BE132254A patent/BE800899R/xx active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH273860A (de) * | 1942-04-25 | 1951-02-28 | Nv Organon | Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe. |
| FR2118117A1 (enExample) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd | |
| FR2118123A1 (enExample) * | 1970-12-17 | 1972-07-28 | Glaxo Lab Ltd |
Also Published As
| Publication number | Publication date |
|---|---|
| DK136157C (enExample) | 1978-01-23 |
| CA1040619A (en) | 1978-10-17 |
| DE2330342A1 (de) | 1974-01-17 |
| GB1434919A (en) | 1976-05-12 |
| AU5693773A (en) | 1974-12-19 |
| LU67790A1 (enExample) | 1973-08-16 |
| NL7308267A (enExample) | 1973-12-18 |
| DK136157B (da) | 1977-08-22 |
| BE800899R (fr) | 1973-12-14 |
| FR2189034B2 (enExample) | 1977-01-21 |
| ZA734037B (en) | 1974-05-29 |